CY1116962T1 - Ανθρωπινες λευκολεκτινες και χρησεις αυτων - Google Patents

Ανθρωπινες λευκολεκτινες και χρησεις αυτων

Info

Publication number
CY1116962T1
CY1116962T1 CY20151100756T CY151100756T CY1116962T1 CY 1116962 T1 CY1116962 T1 CY 1116962T1 CY 20151100756 T CY20151100756 T CY 20151100756T CY 151100756 T CY151100756 T CY 151100756T CY 1116962 T1 CY1116962 T1 CY 1116962T1
Authority
CY
Cyprus
Prior art keywords
wheels
human
polypeptide
disorder
lectin
Prior art date
Application number
CY20151100756T
Other languages
English (en)
Inventor
Bernt Th Walther
Mirushe Miftari
Original Assignee
Leukolect As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leukolect As filed Critical Leukolect As
Publication of CY1116962T1 publication Critical patent/CY1116962T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σε πολυπεπτίδιο, που περιγράφεται ως λεκτίνη, κωδικοποιητική νουκλεϊνικού οξέος αλληλουχία αυτού και αντισώματα προς το πολυπεπτίδιο και χρήση αυτών σε διάφορες ιατρικές εφαρμογές, ιδιαιτέρως για θεραπεία ή πρόληψη αυτοάνοσης διαταραχής, φλεγμονώδους διαταραχής ή δέρματος που έχει υποστεί βλάβη σε ένα ζώο.
CY20151100756T 2010-04-29 2015-08-27 Ανθρωπινες λευκολεκτινες και χρησεις αυτων CY1116962T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1007202.3A GB201007202D0 (en) 2010-04-29 2010-04-29 Product and uses
EP11720057.6A EP2563806B1 (en) 2010-04-29 2011-04-28 Human leukolectins and uses thereof

Publications (1)

Publication Number Publication Date
CY1116962T1 true CY1116962T1 (el) 2017-04-05

Family

ID=42289851

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100756T CY1116962T1 (el) 2010-04-29 2015-08-27 Ανθρωπινες λευκολεκτινες και χρησεις αυτων

Country Status (8)

Country Link
US (1) US9708380B2 (el)
EP (1) EP2563806B1 (el)
CY (1) CY1116962T1 (el)
DK (1) DK2563806T3 (el)
ES (1) ES2546310T3 (el)
GB (1) GB201007202D0 (el)
PT (1) PT2563806E (el)
WO (1) WO2011135059A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0819883D0 (en) * 2008-10-29 2008-12-03 Azyme Res As Product and uses
GB201110777D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
PE20150269A1 (es) 2012-01-23 2015-02-19 Restorsea Llc Composicion cosmetica que contiene una proteina de eclosion de huevo
CN105813627A (zh) 2013-12-13 2016-07-27 雷斯托尔西有限公司 脱落毛发保留促进的制剂
SG11201609241QA (en) 2014-05-16 2016-12-29 Restorsea Llc Biphasic cosmetic
CN105296499A (zh) * 2015-11-03 2016-02-03 中国水产科学研究院淡水渔业研究中心 一种福瑞鲤igf3基因及其扩增引物组和扩增方法
US10926060B2 (en) 2017-03-02 2021-02-23 Covidien Lp Flexible tip catheter

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5608594A (en) 1992-11-16 1994-06-08 Incyte Pharmaceuticals, Inc. Method of causing selective immunosuppression using hl-60-related lectins
NO314594B1 (no) 1997-12-11 2003-04-14 Aqua Bio Technology As Ikke-selvdegraderende endoprotease, fremgangsmåte for fremstilling samt anvendelser av denne
AU766674B2 (en) 1998-05-27 2003-10-23 Lauras As Method
CA2699916A1 (en) * 2007-09-18 2009-08-06 The Jackson Laboratory Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof
GB0819883D0 (en) * 2008-10-29 2008-12-03 Azyme Res As Product and uses

Also Published As

Publication number Publication date
DK2563806T3 (en) 2015-08-10
US9708380B2 (en) 2017-07-18
EP2563806B1 (en) 2015-06-03
PT2563806E (pt) 2015-10-09
WO2011135059A1 (en) 2011-11-03
GB201007202D0 (en) 2010-06-16
ES2546310T3 (es) 2015-09-22
US20130129742A1 (en) 2013-05-23
EP2563806A1 (en) 2013-03-06

Similar Documents

Publication Publication Date Title
CY1119930T1 (el) Λευκολεκτινες και χρησεις αυτων
CY1116962T1 (el) Ανθρωπινες λευκολεκτινες και χρησεις αυτων
CY1124805T1 (el) Φλαγγελινη roseburia και ανοσοτροποποιηση
CY1123552T1 (el) Θεραπειες συνδυασμου με χρηση μοριων προσδεσης psl και pcrv αντι- pseudomonas
CY1123051T1 (el) Ταπενταδολη για προληψη και θεραπεια καταθλιψης και αγχους
CY1118680T1 (el) Φαρμακευτικη συνθεση
CY1124698T1 (el) Πρωτεϊνη δεσμευσης il-18 (il-18bp) σε φλεγμονωδεις νοσους
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
CY1119213T1 (el) Πρωτεϊνη p75ntr συνδεσης νευροτροφινης για θεραπευτικη χρηση
CY1120103T1 (el) Κλιμακωσιμο συστημα παραγωγης λεντιικου φορεα, συμβατο με βιομηχανικες φαρμακευτικες εφαρμογες
EA201791485A1 (ru) Анти-cd47-антитела и их применения
CY1121097T1 (el) Ανθρωπινα αντισωματα κατα toy gfr 3 και μεθοδοι χρησης αυτων
CY1118885T1 (el) Συνθετικες πεπτιδογλυκανες που δεσμευουν υαλουρονικο οξυ, παρασκευη, και μεθοδοι χρησης
CY1119518T1 (el) Τροποποιημενα αντιγονα φυματιωσης
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
CY1120557T1 (el) Μορια δεσμευσης anti-pseudomonas psl και χρησεις αυτων
CY1117372T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες και η χρηση τους
CY1121736T1 (el) Άλατα aramchol
EA201491656A1 (ru) Связывающие молекулы человека, способные связываться с вирусами гриппа в и нейтрализовать их, и их применения
EA201391507A1 (ru) АНТИТЕЛА ПРОТИВ c-Kit И ИХ ПРИМЕНЕНИЕ
CY1120772T1 (el) ΜΕΤΑΛΛΑΓΜΕΝΑ ΘΡΑΥΣΜΑΤΑ OspA ΚΑΙ ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ ΣΧΕΤΙΚΕΣ ΜΕ ΑΥΤΑ
EA201400993A1 (ru) Антитела против рецептора эпидермального фактора роста, активные в определенных условиях, и способы их применения
EA201391119A1 (ru) Системы доставки наночастиц, их получение и применение
CY1119432T1 (el) Αναστολεiς πυραζολυλ-γουανιδινο-f1f0-ατρασης και θεραπευτικες χρησεις αυτωn
CY1123490T1 (el) Συνθεσεις που προερχονται απο χιτοζανη